Skip to content

Optimal Dog Visits

Optimal Dog Visits

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04635124
Enrollment
186
Registered
2020-11-18
Start date
2015-01-01
Completion date
2017-11-01
Last updated
2020-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Dementia

Keywords

Animal-assisted therapy, visiting dog, non-pharmacological, nursing home

Brief summary

The aim of this project is to study how an the intensity of dog contact during dog visits in nursing homes can affect the immediate response to, and the general effect of the visits, and whether the residents' level of cognitive impairment affects the response and benefit of dog visits. The participants are randomly assigned to receive one type of visits (12 visits in total) out of three possible visit types (1: visit with a dog; 2: visit with a dog, including a planned activity, 3 visit without a dog, including a planned activity). The residents received 2 visits per week for 6 weeks. The behaviour of the participants during visits is recorded. Before and after the intervention period, participants are scores on psychometric scales for cognitive impairment level, daily function level and symptoms of depression.

Interventions

BEHAVIORALDog visit

An visitor visits the participant with a dog

BEHAVIORALEncourage to engage in activity

In each visit the visitor invites the participant to engage in an activitty

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The design of the study is a stratified and randomized complete block design. Each nursing home is a block. The participants are allocated randomly to one of the three visit types (1) Visits with a dog, no activity (D); 2) Visits with a dog, with activity (DA); or 3) Visits without dog, with an activity (A), balancing for the level of cognitive impairment, measured by the MMSE-scale. This was achieved by ranking the participants according to MMSE score within sex and allocating them to the three visit types by using different numerical orders in each nursing home (1, 2, 3; 3, 1, 2; 2, 3, 1 etc.).

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

• Being able to sit up during the visits

Exclusion criteria

* Dog allergy * Fear of dogs * Health problems that make participation unadvisable

Design outcomes

Primary

MeasureTime frameDescription
Behavioural response during visitsBehaviour is recorded in all of the 12 visits in the 6 week intervention periodThe behaviour of the residents is recorded by direct observation using continuous recording. In all visits, the frequency and duration of talk and physical contact to the persons present are recorded. Talk is classified into talk about the dog and/or activity, depending on the visit type. In visits with dogs (D, DA), the frequency and duration of physical contact and talk directed to the dog are recorded, and in visits involving an activity (DA, A), the frequency and duration of the residents' involvement in the activity are recorded.

Secondary

MeasureTime frameDescription
Cognitive impairment level, before interventionThis measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )All participants were scored on the Mini-Mental State Examination (MMSE), which gives information about the participants' cognitive status.The MMSE score has a minimum and maximum value of 0 and 30, respectively. The lower the score, the more severe the cognitively impairment level.
Symptoms of depression, before interventionThis measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )All participants were scored on the Geriatric Depression Scale (GDS), to screen for symptoms of depression. The GDS score has a minimum and maximum value of 0 and 15, respectively.A high score indicates more symptoms of depression.
Daily function level, before interventionThis measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )All participants were scored on The Gottfries-Bråne-Steen Scale (GBS), which is an evaluation of disabilities, language, psychiatric symptoms, average daily living function, and behaviour of the participants. The GBS score has a minimum and maximum value of 0 and 156, respectively. The lower the score, the more well-functioning the patient.
Daily function level,, after interventionThis measure is obtained in the week following the intervention period (6 weeks, 2 visits )All participants were scored on The Gottfries-Bråne-Steen Scale (GBS), which is an evaluation of disabilities, language, psychiatric symptoms, average daily living function, and behaviour of the participants. The GBS score has a minimum and maximum value of 0 and 156, respectively. The lower the score, the more well-functioning the patient.
Symptoms of depression, after interventionThis measure is obtained in the week following the intervention period (6 weeks, 2 visits )All participants were scored on the Geriatric Depression Scale (GDS), to screen for symptoms of depression. The GDS score has a minimum and maximum value of 0 and 15, respectively.A high score indicates more symptoms of depression.
Cognitive impairment level, after interventionThis measure is obtained in the week following the intervention period (6 weeks, 2 visits )All participants were scored on the Mini-Mental State Examination (MMSE), which gives information about the participants' cognitive status. The MMSE score has a minimum and maximum value of 0 and 30, respectively. The lower the score, the more severe the cognitively impairment level.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026